Congresswoman Louise M. Slaughter announced a $4.6 million appropriation from the U.S. Department of Defense to the University at Buffalo to purchase a cyclotron to support UB’s $118 million Clinical and Translational Research Center (CTRC).
UB’s CTRC and Biosciences Incubator are currently under construction on the Buffalo Niagara Medical Campus. These facilities will join Kaleida Health’s Global Vascular Institute (GVI) in a new combined $291 million 10-story clinical care, clinical and translational research, and business incubation building to be located next to Buffalo General Hospital at Goodrich and Ellicott streets.
The PETrace cyclotron is an essential research device expected to lead to the development of new therapies and treatments, particularly for cardiovascular diseases, cancer and neurological disorders. The cyclotron will generate radiopharmaceuticals essential for supporting molecular imaging with positron emission tomography (PET), a technology that holds great promise for understanding mechanisms of disease.